Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 37 to 48 of 123 entries
Sorted by: Best Match Show Resources per page
Intercomparison of Small Unmanned Aircraft System (sUAS) Measurements for Atmospheric Science during the LAPSE-RATE Campaign.

Sensors (Basel, Switzerland)

Barbieri L, Kral ST, Bailey SCC, Frazier AE, Jacob JD, Reuder J, Brus D, Chilson PB, Crick C, Detweiler C, Doddi A, Elston J, Foroutan H, González-Rocha J, Greene BR, Guzman MI, Islam ALHA, Kemppinen O, Lawrence D, Pillar-Little EA, Ross SD, Sama M, Schmale DG, Schuyler TJ, Shankar A, Smith SW, Waugh S, Dixon C, Borenstein S, Boer G.
PMID: 31083477
Sensors (Basel). 2019 May 10;19(9). doi: 10.3390/s19092179.

Small unmanned aircraft systems (sUAS) are rapidly transforming atmospheric research. With the advancement of the development and application of these systems, improving knowledge of best practices for accurate measurement is critical for achieving scientific goals. We present results from...

Cite
Barbieri L, Kral ST, Bailey SCC, et al. Intercomparison of Small Unmanned Aircraft System (sUAS) Measurements for Atmospheric Science during the LAPSE-RATE Campaign. Sensors (Basel). 2019;19(9)doi: 10.3390/s19092179.
Barbieri, L., Kral, S. T., Bailey, S. C. C., Frazier, A. E., Jacob, J. D., Reuder, J., Brus, D., Chilson, P. B., Crick, C., Detweiler, C., Doddi, A., Elston, J., Foroutan, H., González-Rocha, J., Greene, B. R., Guzman, M. I., Islam, A. L. H. A., Kemppinen, O., Lawrence, D., Pillar-Little, E. A., Ross, S. D., Sama, M., Schmale, D. G., Schuyler, T. J., Shankar, A., Smith, S. W., Waugh, S., Dixon, C., Borenstein, S., & Boer, G. (2019). Intercomparison of Small Unmanned Aircraft System (sUAS) Measurements for Atmospheric Science during the LAPSE-RATE Campaign. Sensors (Basel, Switzerland), 19(9), . https://doi.org/10.3390/s19092179
Barbieri, Lindsay, et al. "Intercomparison of Small Unmanned Aircraft System (sUAS) Measurements for Atmospheric Science during the LAPSE-RATE Campaign." Sensors (Basel, Switzerland) vol. 19,9 (2019). doi: https://doi.org/10.3390/s19092179
Barbieri L, Kral ST, Bailey SCC, Frazier AE, Jacob JD, Reuder J, Brus D, Chilson PB, Crick C, Detweiler C, Doddi A, Elston J, Foroutan H, González-Rocha J, Greene BR, Guzman MI, Islam ALHA, Kemppinen O, Lawrence D, Pillar-Little EA, Ross SD, Sama M, Schmale DG, Schuyler TJ, Shankar A, Smith SW, Waugh S, Dixon C, Borenstein S, Boer G. Intercomparison of Small Unmanned Aircraft System (sUAS) Measurements for Atmospheric Science during the LAPSE-RATE Campaign. Sensors (Basel). 2019 May 10;19(9). doi: 10.3390/s19092179. PMID: 31083477; PMCID: PMC6540006.
Copy Download .nbib Format: NLM
First Scandinavian Protocol for Controlled Donation After Circulatory Death Using Normothermic Regional Perfusion.

Transplantation direct

Foss S, Nordheim E, Sørensen DW, Syversen TB, Midtvedt K, Åsberg A, Dahl T, Bakkan PA, Foss AE, Geiran OR, Fiane AE, Line PD.
PMID: 30046656
Transplant Direct. 2018 Jun 13;4(7):e366. doi: 10.1097/TXD.0000000000000802. eCollection 2018 Jul.

BACKGROUND: Donation after circulatory death (DCD) can increase the pool of available organs for transplantation. This pilot study evaluates the implementation of a controlled DCD (cDCD) protocol using normothermic regional perfusion in Norway.METHODS: Patients aged 16 to 60 years...

Cite
Foss S, Nordheim E, Sørensen DW, et al. First Scandinavian Protocol for Controlled Donation After Circulatory Death Using Normothermic Regional Perfusion. Transplant Direct. 2018;4(7):e366doi: 10.1097/TXD.0000000000000802.
Foss, S., Nordheim, E., Sørensen, D. W., Syversen, T. B., Midtvedt, K., Åsberg, A., Dahl, T., Bakkan, P. A., Foss, A. E., Geiran, O. R., Fiane, A. E., & Line, P. D. (2018). First Scandinavian Protocol for Controlled Donation After Circulatory Death Using Normothermic Regional Perfusion. Transplantation direct, 4(7), e366. https://doi.org/10.1097/TXD.0000000000000802
Foss, Stein, et al. "First Scandinavian Protocol for Controlled Donation After Circulatory Death Using Normothermic Regional Perfusion." Transplantation direct vol. 4,7 (2018): e366. doi: https://doi.org/10.1097/TXD.0000000000000802
Foss S, Nordheim E, Sørensen DW, Syversen TB, Midtvedt K, Åsberg A, Dahl T, Bakkan PA, Foss AE, Geiran OR, Fiane AE, Line PD. First Scandinavian Protocol for Controlled Donation After Circulatory Death Using Normothermic Regional Perfusion. Transplant Direct. 2018 Jun 13;4(7):e366. doi: 10.1097/TXD.0000000000000802. eCollection 2018 Jul. PMID: 30046656; PMCID: PMC6056274.
Copy Download .nbib Format: NLM
Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors.

Advances in urology

Fung C, Dinh P, Ardeshir-Rouhani-Fard S, Schaffer K, Fossa SD, Travis LB.
PMID: 29670654
Adv Urol. 2018 Feb 18;2018:8671832. doi: 10.1155/2018/8671832. eCollection 2018.

Testicular cancer has become the paradigm of adult-onset cancer survivorship, due to the young age at diagnosis and 10-year relative survival of 95%. This clinical review presents the current status of various treatment-related complications experienced by long-term testicular cancer...

Cite
Fung C, Dinh P, Ardeshir-Rouhani-Fard S, et al. Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors. Adv Urol. 2018;2018:8671832doi: 10.1155/2018/8671832.
Fung, C., Dinh, P., Ardeshir-Rouhani-Fard, S., Schaffer, K., Fossa, S. D., & Travis, L. B. (2018). Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors. Advances in urology, 20188671832. https://doi.org/10.1155/2018/8671832
Fung, Chunkit, et al. "Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors." Advances in urology vol. 2018 (2018): 8671832. doi: https://doi.org/10.1155/2018/8671832
Fung C, Dinh P, Ardeshir-Rouhani-Fard S, Schaffer K, Fossa SD, Travis LB. Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors. Adv Urol. 2018 Feb 18;2018:8671832. doi: 10.1155/2018/8671832. eCollection 2018. PMID: 29670654; PMCID: PMC5835297.
Copy Download .nbib Format: NLM
Re: Thyroid hypofunction in aging testicular cancer survivors by Nome et al.

Acta oncologica (Stockholm, Sweden)

Nome RV, Småstuen MC, Fosså SD, Kiserud CE, Åsvold BO, Bjøro T.
PMID: 35037554
Acta Oncol. 2022 Jan 16;1. doi: 10.1080/0284186X.2021.2023214. Epub 2022 Jan 16.

No abstract available.

Cite
Nome RV, Småstuen MC, Fosså SD, et al. Re: Thyroid hypofunction in aging testicular cancer survivors by Nome et al. Acta Oncol. 2022;1doi: 10.1080/0284186X.2021.2023214.
Nome, R. V., Småstuen, M. C., Fosså, S. D., Kiserud, C. E., Åsvold, B. O., & Bjøro, T. (2022). Re: Thyroid hypofunction in aging testicular cancer survivors by Nome et al. Acta oncologica (Stockholm, Sweden), 1. https://doi.org/10.1080/0284186X.2021.2023214
Nome, Ragnhild Veline, et al. "Re: Thyroid hypofunction in aging testicular cancer survivors by Nome et al." Acta oncologica (Stockholm, Sweden) vol. (2022): 1. doi: https://doi.org/10.1080/0284186X.2021.2023214
Nome RV, Småstuen MC, Fosså SD, Kiserud CE, Åsvold BO, Bjøro T. Re: Thyroid hypofunction in aging testicular cancer survivors by Nome et al. Acta Oncol. 2022 Jan 16;1. doi: 10.1080/0284186X.2021.2023214. Epub 2022 Jan 16. PMID: 35037554.
Copy Download .nbib Format: NLM
Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study.

Cancers

van der Perk MEM, Broer L, Yasui Y, Robison LL, Hudson MM, Laven JSE, van der Pal HJ, Tissing WJE, Versluys B, Bresters D, Kaspers GJL, de Vries ACH, Lambalk CB, Overbeek A, Loonen JJ, Beerendonk CCM, Byrne J, Berger C, Clemens E, Dirksen U, Falck Winther J, Fosså SD, Grabow D, Muraca M, Kaiser M, Kepák T, Kruseova J, Modan-Moses D, Spix C, Zolk O, Kaatsch P, Krijthe JH, Kremer LCM, Brooke RJ, Baedke JL, van Schaik RHN, van den Anker JN, Uitterlinden AG, Bos AME, van Leeuwen FE, van Dulmen-den Broeder E, van der Kooi ALF, van den Heuvel-Eibrink MM, On Behalf Of The PanCareLIFE Consortium.
PMID: 34572825
Cancers (Basel). 2021 Sep 13;13(18). doi: 10.3390/cancers13184598.

CONCLUSIONS: Female CCSs

Cite
van der Perk MEM, Broer L, Yasui Y, et al. Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study. Cancers (Basel). 2021;13(18)doi: 10.3390/cancers13184598.
van der Perk, M. E. M., Broer, L., Yasui, Y., Robison, L. L., Hudson, M. M., Laven, J. S. E., van der Pal, H. J., Tissing, W. J. E., Versluys, B., Bresters, D., Kaspers, G. J. L., de Vries, A. C. H., Lambalk, C. B., Overbeek, A., Loonen, J. J., Beerendonk, C. C. M., Byrne, J., Berger, C., Clemens, E., Dirksen, U., Falck Winther, J., Fosså, S. D., Grabow, D., Muraca, M., Kaiser, M., Kepák, T., Kruseova, J., Modan-Moses, D., Spix, C., Zolk, O., Kaatsch, P., Krijthe, J. H., Kremer, L. C. M., Brooke, R. J., Baedke, J. L., van Schaik, R. H. N., van den Anker, J. N., Uitterlinden, A. G., Bos, A. M. E., van Leeuwen, F. E., van Dulmen-den Broeder, E., van der Kooi, A. L. F., van den Heuvel-Eibrink, M. M., & On Behalf Of The PanCareLIFE Consortium. (2021). Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study. Cancers, 13(18), . https://doi.org/10.3390/cancers13184598
van der Perk, M E Madeleine, et al. "Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study." Cancers vol. 13,18 (2021). doi: https://doi.org/10.3390/cancers13184598
van der Perk MEM, Broer L, Yasui Y, Robison LL, Hudson MM, Laven JSE, van der Pal HJ, Tissing WJE, Versluys B, Bresters D, Kaspers GJL, de Vries ACH, Lambalk CB, Overbeek A, Loonen JJ, Beerendonk CCM, Byrne J, Berger C, Clemens E, Dirksen U, Falck Winther J, Fosså SD, Grabow D, Muraca M, Kaiser M, Kepák T, Kruseova J, Modan-Moses D, Spix C, Zolk O, Kaatsch P, Krijthe JH, Kremer LCM, Brooke RJ, Baedke JL, van Schaik RHN, van den Anker JN, Uitterlinden AG, Bos AME, van Leeuwen FE, van Dulmen-den Broeder E, van der Kooi ALF, van den Heuvel-Eibrink MM, On Behalf Of The PanCareLIFE Consortium. Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study. Cancers (Basel). 2021 Sep 13;13(18). doi: 10.3390/cancers13184598. PMID: 34572825; PMCID: PMC8470074.
Copy Download .nbib Format: NLM
ACCELERATE: A Patient-Powered Natural History Study Design Enabling Clinical and Therapeutic Discoveries in a Rare Disorder.

Cell reports. Medicine

Pierson SK, Khor JS, Ziglar J, Liu A, Floess K, NaPier E, Gorzewski AM, Tamakloe MA, Powers V, Akhter F, Haljasmaa E, Jayanthan R, Rubenstein A, Repasky M, Elenitoba-Johnson K, Ruth J, Jacobs B, Streetly M, Angenendt L, Patier JL, Ferrero S, Zinzani PL, Terriou L, Casper C, Jaffe E, Hoffmann C, Oksenhendler E, Fosså A, Srkalovic G, Chadburn A, Uldrick TS, Lim M, van Rhee F, Fajgenbaum DC.
PMID: 33377129
Cell Rep Med. 2020 Dec 22;1(9):100158. doi: 10.1016/j.xcrm.2020.100158. eCollection 2020 Dec 22.

Geographically dispersed patients, inconsistent treatment tracking, and limited infrastructure slow research for many orphan diseases. We assess the feasibility of a patient-powered study design to overcome these challenges for Castleman disease, a rare hematologic disorder. Here, we report initial...

Cite
Pierson SK, Khor JS, Ziglar J, et al. ACCELERATE: A Patient-Powered Natural History Study Design Enabling Clinical and Therapeutic Discoveries in a Rare Disorder. Cell Rep Med. 2020;1(9):100158doi: 10.1016/j.xcrm.2020.100158.
Pierson, S. K., Khor, J. S., Ziglar, J., Liu, A., Floess, K., NaPier, E., Gorzewski, A. M., Tamakloe, M. A., Powers, V., Akhter, F., Haljasmaa, E., Jayanthan, R., Rubenstein, A., Repasky, M., Elenitoba-Johnson, K., Ruth, J., Jacobs, B., Streetly, M., Angenendt, L., Patier, J. L., Ferrero, S., Zinzani, P. L., Terriou, L., Casper, C., Jaffe, E., Hoffmann, C., Oksenhendler, E., Fosså, A., Srkalovic, G., Chadburn, A., Uldrick, T. S., Lim, M., van Rhee, F., & Fajgenbaum, D. C. (2020). ACCELERATE: A Patient-Powered Natural History Study Design Enabling Clinical and Therapeutic Discoveries in a Rare Disorder. Cell reports. Medicine, 1(9), 100158. https://doi.org/10.1016/j.xcrm.2020.100158
Pierson, Sheila K, et al. "ACCELERATE: A Patient-Powered Natural History Study Design Enabling Clinical and Therapeutic Discoveries in a Rare Disorder." Cell reports. Medicine vol. 1,9 (2020): 100158. doi: https://doi.org/10.1016/j.xcrm.2020.100158
Pierson SK, Khor JS, Ziglar J, Liu A, Floess K, NaPier E, Gorzewski AM, Tamakloe MA, Powers V, Akhter F, Haljasmaa E, Jayanthan R, Rubenstein A, Repasky M, Elenitoba-Johnson K, Ruth J, Jacobs B, Streetly M, Angenendt L, Patier JL, Ferrero S, Zinzani PL, Terriou L, Casper C, Jaffe E, Hoffmann C, Oksenhendler E, Fosså A, Srkalovic G, Chadburn A, Uldrick TS, Lim M, van Rhee F, Fajgenbaum DC. ACCELERATE: A Patient-Powered Natural History Study Design Enabling Clinical and Therapeutic Discoveries in a Rare Disorder. Cell Rep Med. 2020 Dec 22;1(9):100158. doi: 10.1016/j.xcrm.2020.100158. eCollection 2020 Dec 22. PMID: 33377129; PMCID: PMC7762771.
Copy Download .nbib Format: NLM
A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome.

JCI insight

Hoel F, Hoel A, Pettersen IK, Rekeland IG, Risa K, Alme K, Sørland K, Fosså A, Lien K, Herder I, Thürmer HL, Gotaas ME, Schäfer C, Berge RK, Sommerfelt K, Marti HP, Dahl O, Mella O, Fluge Ø, Tronstad KJ.
PMID: 34423789
JCI Insight. 2021 Aug 23;6(16). doi: 10.1172/jci.insight.149217.

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating disease usually presenting after infection. Emerging evidence supports that energy metabolism is affected in ME/CFS, but a unifying metabolic phenotype has not been firmly established. We performed global metabolomics, lipidomics, and...

Cite
Hoel F, Hoel A, Pettersen IK, et al. A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome. JCI Insight. 2021;6(16)doi: 10.1172/jci.insight.149217.
Hoel, F., Hoel, A., Pettersen, I. K., Rekeland, I. G., Risa, K., Alme, K., Sørland, K., Fosså, A., Lien, K., Herder, I., Thürmer, H. L., Gotaas, M. E., Schäfer, C., Berge, R. K., Sommerfelt, K., Marti, H. P., Dahl, O., Mella, O., Fluge, �. �., & Tronstad, K. J. (2021). A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome. JCI insight, 6(16), . https://doi.org/10.1172/jci.insight.149217
Hoel, Fredrik, et al. "A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome." JCI insight vol. 6,16 (2021). doi: https://doi.org/10.1172/jci.insight.149217
Hoel F, Hoel A, Pettersen IK, Rekeland IG, Risa K, Alme K, Sørland K, Fosså A, Lien K, Herder I, Thürmer HL, Gotaas ME, Schäfer C, Berge RK, Sommerfelt K, Marti HP, Dahl O, Mella O, Fluge Ø, Tronstad KJ. A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome. JCI Insight. 2021 Aug 23;6(16). doi: 10.1172/jci.insight.149217. PMID: 34423789; PMCID: PMC8409979.
Copy Download .nbib Format: NLM
Effectiveness of Supplementary Materials in Teaching the Veterinary Neurologic Examination.

Journal of veterinary medical education

Foss KD, Seals CDA, Hague DW, Mitek AE.
PMID: 34115578
J Vet Med Educ. 2021 Jun 11;e20210014. doi: 10.3138/jvme-2021-0014. Epub 2021 Jun 11.

Clinical neurology can be difficult for veterinary students to comprehend, and part of understanding the clinical aspect is performing a proper neurologic examination. In this study, first-year veterinary students in a Small Animal Physical Exam and Anatomy rotation were...

Cite
Foss KD, Seals CDA, Hague DW, et al. Effectiveness of Supplementary Materials in Teaching the Veterinary Neurologic Examination. J Vet Med Educ. 2021;e20210014doi: 10.3138/jvme-2021-0014.
Foss, K. D., Seals, C. D. A., Hague, D. W., & Mitek, A. E. (2021). Effectiveness of Supplementary Materials in Teaching the Veterinary Neurologic Examination. Journal of veterinary medical education, e20210014. https://doi.org/10.3138/jvme-2021-0014
Foss, Kari D, et al. "Effectiveness of Supplementary Materials in Teaching the Veterinary Neurologic Examination." Journal of veterinary medical education vol. (2021): e20210014. doi: https://doi.org/10.3138/jvme-2021-0014
Foss KD, Seals CDA, Hague DW, Mitek AE. Effectiveness of Supplementary Materials in Teaching the Veterinary Neurologic Examination. J Vet Med Educ. 2021 Jun 11;e20210014. doi: 10.3138/jvme-2021-0014. Epub 2021 Jun 11. PMID: 34115578.
Copy Download .nbib Format: NLM
Late-Onset, Noninfectious Pulmonary Complications following Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Cohort Study of Long-Term Survivors.

Respiration; international review of thoracic diseases

Myrdal OH, Aaløkken TM, Diep PP, Ruud E, Brinch L, Fosså K, Mangseth H, Kongerud J, Sikkeland LI, Lund MB.
PMID: 34937032
Respiration. 2021 Dec 22;1-9. doi: 10.1159/000520824. Epub 2021 Dec 22.

BACKGROUND: Survivors of allogeneic hematopoietic stem cell transplantation (allo-HSCT) are at risk for pulmonary adverse events. Data on late-onset noninfectious pulmonary complications in long-term adult survivors of allo-HSCT are limited and incomplete.OBJECTIVES: This study aimed (1) to determine occurrence...

Cite
Myrdal OH, Aaløkken TM, Diep PP, et al. Late-Onset, Noninfectious Pulmonary Complications following Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Cohort Study of Long-Term Survivors. Respiration. 2021;1-9doi: 10.1159/000520824.
Myrdal, O. H., Aaløkken, T. M., Diep, P. P., Ruud, E., Brinch, L., Fosså, K., Mangseth, H., Kongerud, J., Sikkeland, L. I., & Lund, M. B. (2021). Late-Onset, Noninfectious Pulmonary Complications following Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Cohort Study of Long-Term Survivors. Respiration; international review of thoracic diseases, 1-9. https://doi.org/10.1159/000520824
Myrdal, Ole Henrik, et al. "Late-Onset, Noninfectious Pulmonary Complications following Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Cohort Study of Long-Term Survivors." Respiration; international review of thoracic diseases vol. (2021): 1-9. doi: https://doi.org/10.1159/000520824
Myrdal OH, Aaløkken TM, Diep PP, Ruud E, Brinch L, Fosså K, Mangseth H, Kongerud J, Sikkeland LI, Lund MB. Late-Onset, Noninfectious Pulmonary Complications following Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Cohort Study of Long-Term Survivors. Respiration. 2021 Dec 22;1-9. doi: 10.1159/000520824. Epub 2021 Dec 22. PMID: 34937032.
Copy Download .nbib Format: NLM
Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome.

JCI insight

Fluge Ø, Mella O, Bruland O, Risa K, Dyrstad SE, Alme K, Rekeland IG, Sapkota D, Røsland GV, Fosså A, Ktoridou-Valen I, Lunde S, Sørland K, Lien K, Herder I, Thürmer H, Gotaas ME, Baranowska KA, Bohnen LM, Schäfer C, McCann A, Sommerfelt K, Helgeland L, Ueland PM, Dahl O, Tronstad KJ.
PMID: 28018972
JCI Insight. 2016 Dec 22;1(21):e89376. doi: 10.1172/jci.insight.89376.

Myalgic encephalopathy/chronic fatigue syndrome (ME/CFS) is a debilitating disease of unknown etiology, with hallmark symptoms including postexertional malaise and poor recovery. Metabolic dysfunction is a plausible contributing factor. We hypothesized that changes in serum amino acids may disclose specific...

Cite
Fluge Ø, Mella O, Bruland O, et al. Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome. JCI Insight. 2016;1(21):e89376doi: 10.1172/jci.insight.89376.
Fluge, �. �., Mella, O., Bruland, O., Risa, K., Dyrstad, S. E., Alme, K., Rekeland, I. G., Sapkota, D., Røsland, G. V., Fosså, A., Ktoridou-Valen, I., Lunde, S., Sørland, K., Lien, K., Herder, I., Thürmer, H., Gotaas, M. E., Baranowska, K. A., Bohnen, L. M., Schäfer, C., McCann, A., Sommerfelt, K., Helgeland, L., Ueland, P. M., Dahl, O., & Tronstad, K. J. (2016). Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome. JCI insight, 1(21), e89376. https://doi.org/10.1172/jci.insight.89376
Fluge, Øystein, et al. "Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome." JCI insight vol. 1,21 (2016): e89376. doi: https://doi.org/10.1172/jci.insight.89376
Fluge Ø, Mella O, Bruland O, Risa K, Dyrstad SE, Alme K, Rekeland IG, Sapkota D, Røsland GV, Fosså A, Ktoridou-Valen I, Lunde S, Sørland K, Lien K, Herder I, Thürmer H, Gotaas ME, Baranowska KA, Bohnen LM, Schäfer C, McCann A, Sommerfelt K, Helgeland L, Ueland PM, Dahl O, Tronstad KJ. Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome. JCI Insight. 2016 Dec 22;1(21):e89376. doi: 10.1172/jci.insight.89376. PMID: 28018972; PMCID: PMC5161229.
Copy Download .nbib Format: NLM
Sodium activates human monocytes via the NADPH oxidase and isolevuglandin formation.

Cardiovascular research

Ruggeri Barbaro N, Van Beusecum J, Xiao L, do Carmo L, Pitzer A, Loperena R, Foss JD, Elijovich F, Laffer CL, Montaniel KR, Galindo CL, Chen W, Ao M, Mernaugh RL, Alsouqi A, Ikizler TA, Fogo AB, Moreno H, Zhao S, Davies SS, Harrison DG, Kirabo A.
PMID: 33038226
Cardiovasc Res. 2021 Apr 23;117(5):1358-1371. doi: 10.1093/cvr/cvaa207.

AIMS: Prior studies have focused on the role of the kidney and vasculature in salt-induced modulation of blood pressure; however, recent data indicate that sodium accumulates in tissues and can activate immune cells. We sought to examine mechanisms by...

Cite
Ruggeri Barbaro N, Van Beusecum J, Xiao L, et al. Sodium activates human monocytes via the NADPH oxidase and isolevuglandin formation. Cardiovasc Res. 2021;117(5):1358-1371doi: 10.1093/cvr/cvaa207.
Ruggeri Barbaro, N., Van Beusecum, J., Xiao, L., do Carmo, L., Pitzer, A., Loperena, R., Foss, J. D., Elijovich, F., Laffer, C. L., Montaniel, K. R., Galindo, C. L., Chen, W., Ao, M., Mernaugh, R. L., Alsouqi, A., Ikizler, T. A., Fogo, A. B., Moreno, H., Zhao, S., Davies, S. S., Harrison, D. G., & Kirabo, A. (2021). Sodium activates human monocytes via the NADPH oxidase and isolevuglandin formation. Cardiovascular research, 117(5), 1358-1371. https://doi.org/10.1093/cvr/cvaa207
Ruggeri Barbaro, Natalia, et al. "Sodium activates human monocytes via the NADPH oxidase and isolevuglandin formation." Cardiovascular research vol. 117,5 (2021): 1358-1371. doi: https://doi.org/10.1093/cvr/cvaa207
Ruggeri Barbaro N, Van Beusecum J, Xiao L, do Carmo L, Pitzer A, Loperena R, Foss JD, Elijovich F, Laffer CL, Montaniel KR, Galindo CL, Chen W, Ao M, Mernaugh RL, Alsouqi A, Ikizler TA, Fogo AB, Moreno H, Zhao S, Davies SS, Harrison DG, Kirabo A. Sodium activates human monocytes via the NADPH oxidase and isolevuglandin formation. Cardiovasc Res. 2021 Apr 23;117(5):1358-1371. doi: 10.1093/cvr/cvaa207. PMID: 33038226; PMCID: PMC8064439.
Copy Download .nbib Format: NLM
Seven-year trajectories of body weight, quality of life and comorbidities following Roux-en-Y gastric bypass and sleeve gastrectomy.

International journal of obesity (2005)

Nielsen HJ, Nedrebø BG, Fosså A, Andersen JR, Assmus J, Dagsland VH, Dankel SN, Gudbrandsen OA, Fernø J, Hjellestad I, Hjermstad MJ, Kolotkin RL, Thorsen HL, Mellgren G, Flølo TN.
PMID: 34974544
Int J Obes (Lond). 2022 Jan 01; doi: 10.1038/s41366-021-01028-5. Epub 2022 Jan 01.

BACKGROUND/OBJECTIVES: There is limited long-term data comparing the outcomes of sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) for severe obesity, both with respect to body weight, quality of life (QOL) and comorbidities. We aimed to determine 7-year trajectories...

Cite
Nielsen HJ, Nedrebø BG, Fosså A, et al. Seven-year trajectories of body weight, quality of life and comorbidities following Roux-en-Y gastric bypass and sleeve gastrectomy. Int J Obes (Lond). 2022;doi: 10.1038/s41366-021-01028-5.
Nielsen, H. J., Nedrebø, B. G., Fosså, A., Andersen, J. R., Assmus, J., Dagsland, V. H., Dankel, S. N., Gudbrandsen, O. A., Fernø, J., Hjellestad, I., Hjermstad, M. J., Kolotkin, R. L., Thorsen, H. L., Mellgren, G., & Flølo, T. N. (2022). Seven-year trajectories of body weight, quality of life and comorbidities following Roux-en-Y gastric bypass and sleeve gastrectomy. International journal of obesity (2005), . https://doi.org/10.1038/s41366-021-01028-5
Nielsen, Hans Jørgen, et al. "Seven-year trajectories of body weight, quality of life and comorbidities following Roux-en-Y gastric bypass and sleeve gastrectomy." International journal of obesity (2005) vol. (2022). doi: https://doi.org/10.1038/s41366-021-01028-5
Nielsen HJ, Nedrebø BG, Fosså A, Andersen JR, Assmus J, Dagsland VH, Dankel SN, Gudbrandsen OA, Fernø J, Hjellestad I, Hjermstad MJ, Kolotkin RL, Thorsen HL, Mellgren G, Flølo TN. Seven-year trajectories of body weight, quality of life and comorbidities following Roux-en-Y gastric bypass and sleeve gastrectomy. Int J Obes (Lond). 2022 Jan 01; doi: 10.1038/s41366-021-01028-5. Epub 2022 Jan 01. PMID: 34974544.
Copy Download .nbib Format: NLM
Showing 37 to 48 of 123 entries